These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 1535100)

  • 1. The effect of a synthetic GnRH analogue on catamenial epilepsy: a study in ten patients.
    Bauer J; Wildt L; Flügel D; Stefan H
    J Neurol; 1992 May; 239(5):284-6. PubMed ID: 1535100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Catamenial seizures--an analysis].
    Bauer J; Hocke A; Elger CE
    Nervenarzt; 1995 Oct; 66(10):760-9. PubMed ID: 7501092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Etiology, follow-up and therapy of seizure clusters in temporal lobe epilepsy and catamenial epileptic seizures].
    Bauer J; Ghane Y; Flügel D; Wildt L; Stefan H
    Schweiz Arch Neurol Psychiatr (1985); 1992; 143(2):117-34. PubMed ID: 1375777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catamenial epilepsy: hormonal aspects.
    Verrotti A; Laus M; Coppola G; Parisi P; Mohn A; Chiarelli F
    Gynecol Endocrinol; 2010 Nov; 26(11):783-90. PubMed ID: 20518639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Catamenial epilepsy].
    Mehmedika-Suljić E; Alajbegović A; Loncarević N; Alajbegović S
    Med Arh; 2007; 61(4):248-9. PubMed ID: 18298002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacology of catamenial epilepsy.
    Reddy DS
    Methods Find Exp Clin Pharmacol; 2004 Sep; 26(7):547-61. PubMed ID: 15538544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catamenial epilepsy: pathophysiology, diagnosis, and management.
    Foldvary-Schaefer N; Falcone T
    Neurology; 2003 Sep; 61(6 Suppl 2):S2-15. PubMed ID: 14504304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of neurosteroids in the pathophysiology and treatment of catamenial epilepsy.
    Reddy DS
    Epilepsy Res; 2009 Jul; 85(1):1-30. PubMed ID: 19406620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catamenial Epilepsy: The Menstrual Cycle as a Clue to Predict Future Refractory Seizures.
    Khishfe BF
    J Emerg Med; 2017 Feb; 52(2):235-237. PubMed ID: 27687170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormones and seizures.
    Foldvary-Schaefer N; Harden C; Herzog A; Falcone T
    Cleve Clin J Med; 2004 Feb; 71 Suppl 2():S11-8. PubMed ID: 15379295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-finding study for the use of long-acting gonadotrophin-releasing hormone analogues prior to ovarian stimulation for IVF.
    Yim SF; Lok IH; Cheung LP; Briton-Jones CM; Chiu TT; Haines CJ
    Hum Reprod; 2001 Mar; 16(3):492-4. PubMed ID: 11228217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation.
    European and Middle East Orgalutran Study Group
    Hum Reprod; 2001 Apr; 16(4):644-51. PubMed ID: 11278211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of catamenial seizure exacerbation in women with localization-related epilepsy.
    Herzog AG; Harden CL; Liporace J; Pennell P; Schomer DL; Sperling M; Fowler K; Nikolov B; Shuman S; Newman M
    Ann Neurol; 2004 Sep; 56(3):431-4. PubMed ID: 15349872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormonal effects on epilepsy in women.
    Klein P; Herzog AG
    Epilepsia; 1998; 39 Suppl 8():S9-16. PubMed ID: 9915615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three patterns of catamenial epilepsy.
    Herzog AG; Klein P; Ransil BJ
    Epilepsia; 1997 Oct; 38(10):1082-8. PubMed ID: 9579954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progesterone therapy in women with epilepsy.
    Motta E; Golba A; Ostrowska Z; Steposz A; Huc M; Kotas-Rusnak J; Łuszczki JJ; Czuczwar SJ; Lasoń W
    Pharmacol Rep; 2013; 65(1):89-98. PubMed ID: 23563027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single dose GnRH agonist administration in the luteal phase of assisted reproduction cycles: is the effect dependent on the type of GnRH analogue used for pituitary suppression?
    Ata B; Urman B
    Reprod Biomed Online; 2010 Jan; 20(1):165-6; author reply 167. PubMed ID: 20159003
    [No Abstract]   [Full Text] [Related]  

  • 18. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH.
    Filicori M; Campaniello E; Michelacci L; Pareschi A; Ferrari P; Bolelli G; Flamigni C
    J Clin Endocrinol Metab; 1988 Feb; 66(2):327-33. PubMed ID: 3123511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antagonistic and agonistic GnRH analogue treatment of precocious puberty: tracking gonadotropin concentrations in urine.
    Roth CL; Brendel L; Rückert C; Hartmann K
    Horm Res; 2005; 63(5):257-62. PubMed ID: 15995342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Issues for Women with Epilepsy.
    Vélez-Ruiz NJ; Pennell PB
    Neurol Clin; 2016 May; 34(2):411-25, ix. PubMed ID: 27086987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.